Enteric Neuromuscular Manifestations in Neurofibromatosis Type I
Neurogastroenterology & Motility · 2025-12 · 37 (12)
DOI: 10.1111/nmo.70101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 10.06.2025. Verfasst von John A Damianos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Division of Gastroenterology and Hepatology, Mayo Clinic, Ro…. Hauptthemen laut MEDLINE: Neurofibromatosis 1, Enteric Nervous System, Gastrointestinal Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
Several genetic syndromes that affect nerve development and functioning may involve the enteric nervous system and present clinically as dysmotility syndromes, typically in childhood.
Aim
To review the enteric neuromuscular manifestations, predominantly observed in adults, of neurofibromatosis type I at a tertiary referral center.
Methods
We conducted a medical records review at the Mayo Clinic and documented clinical manifestations and findings on radiology, pathology, and specialized motility tests of the esophagus, stomach, colon, and rectal evacuatory functions. The tests included scintigraphic gastrointestinal and colonic transit measurements, intraluminal esophageal, gastrointestinal, colonic, and anorectal manometry, and balloon expulsion test.
Results
Among 2406 with documented NF1, the gastrointestinal manifestations were obstruction or dysmotility, seen in 2% of the cohort. Thirteen patients had small bowel or colonic obstructions: 4 gastrointestinal stromal tumors, 3 malignant peripheral nerve sheath tumors, 3 neurofibromas, 1 diffuse ganglioneuromatosis, 1 schwannoma, and 1 inflammatory fibroid polyp. In addition, 38 patients had abnormal gut motility, including esophageal achalasia or spasm, delayed gastric emptying, slow colonic transit, and dyssynergic defecation. Gastric, small bowel, and colonic manometry were characterized by normal amplitude incoordinated contractions suggestive of neuropathy. In the few resected specimens, myenteric plexus proliferation or diffuse ganglioneuromatosis was identified histologically.
Conclusions
In addition to mechanical obstruction, typically due to benign tumors affecting smooth muscle or components of nerve (sheath or nerve fiber), patients with NF1 may present with dysmotility syndromes such as gastroparesis, slow colonic transit, or global dysmotility. Neuropathic dysmotility in NF1 can be identified by manometry and by histological evidence of myenteric plexus proliferation or diffuse ganglioneuromatosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: John A Damianos, Michael Camilleri
Zitieren
APA
Damianos, J. A., Matkowskyj, K. A., & Camilleri, M. (2025). Enteric Neuromuscular Manifestations in Neurofibromatosis Type I. Neurogastroenterology & Motility, 37(12). https://doi.org/10.1111/nmo.70101
Vancouver
Damianos JA, Matkowskyj KA, Camilleri M. Enteric Neuromuscular Manifestations in Neurofibromatosis Type I. Neurogastroenterology & Motility. 2025;37(12). doi:10.1111/nmo.70101
BibTeX
@article{Damianos2025,
author = {Damianos, John A and Matkowskyj, Kristina A and Camilleri, Michael},
title = {Enteric Neuromuscular Manifestations in Neurofibromatosis Type I},
journal = {Neurogastroenterology & Motility},
year = {2025},
volume = {37},
number = {12},
doi = {10.1111/nmo.70101}
}
EUVIMED